Chair of the Academic Board
Council Member and Trustee
Royal Society of Medicine
London UK
andrew.krentz@rsm.ac.uk
Andrew Krentz is a practising physician, clinical researcher, medical educator, founding journal editor, innovator and author of a series of medical textbooks. He graduated from the University of Birmingham UK and gained postgraduate clinical and research experience at leading academic and life science institutions in the UK and USA.
His research MD (University of Birmingham 1991) thesis was titled Metabolic Studies in Insulin Resistance. Andrew has held four professorial-level appointments including current visiting chairs at King’s College London and the University of Reading UK. He is recognized for personal contributions to translational medicine that have become established in clinical practice and research.
Andrew’s clinical interests encompass the cardiometabolic spectrum of disease including diabetes and endocrinology, hypertension, lipid metabolism and cardiovascular disease. With international collaborators drawn from a range of clinical specialties his aim is to improve care for people living with long-term cardiometabolic disorders.
He is also developing personalised precision medicine for long-term multimorbid cardiometabolic diseases as Chief Medical Officer of an artificial intelligence startup. In addition to his senior leadership role at the Royal Society of Medicine Andrew is actively exploring the value of human-centred design in undergraduate and postgraduate medical education with colleagues at the Royal Society of Arts. In 2025 Andrew will be a visiting research fellow at the transdisciplinary Santa Fe Institute USA where he will explore the evolving role of insulin in health and disease.